Pages that link to "Q54240459"

The following pages link to Drug resistance and Giardia. (Q54240459):

Displaying 45 items.

• A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis (Q21144530) (← links)
• Induction of resistance to azole drugs in Trypanosoma cruzi (Q24519052) (← links)
• Drug targets and mechanisms of resistance in the anaerobic protozoa (Q24550694) (← links)
• A data-driven predictive approach for drug delivery using machine learning techniques (Q28481230) (← links)
• Drug resistance among malaria and other parasites (Q32156246) (← links)
• Replacement of the essential Dictyostelium Arp2 gene by its Entamoeba homologue using parasexual genetics (Q33286954) (← links)
• Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp (Q33975866) (← links)
• Drug susceptibility testing of anaerobic protozoa (Q33982334) (← links)
• Anaerobic bacterial metabolism in the ancient eukaryote Giardia duodenalis (Q34460598) (← links)
• Diagnostic advantages and therapeutic options for giardiasis (Q34481652) (← links)
• Zoonotic Potential and Molecular Epidemiology ofGiardiaSpecies and Giardiasis (Q34491543) (← links)
• A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities (Q34528996) (← links)
• Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites (Q34601985) (← links)
• Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis (Q35219218) (← links)
• Impaired Parasite Attachment as Fitness Cost of Metronidazole Resistance in Giardia lamblia (Q35270323) (← links)
• Phenotypic and transcriptional profiling in Entamoeba histolytica reveal costs to fitness and adaptive responses associated with metronidazole resistance (Q35569960) (← links)
• Efficacy of antigiardial drugs (Q35570972) (← links)
• Physical map of a 2 Mb chromosome of the intestinal protozoan parasite Giardia duodenalis (Q36722931) (← links)
• The public health and clinical significance of Giardia and Cryptosporidium in domestic animals (Q37010853) (← links)
• Barcoding of Giardia duodenalis isolates and derived lines from an established cryobank by a mutation scanning-based approach (Q37260581) (← links)
• Current treatment options for Dientamoeba fragilis infections. (Q37390538) (← links)
• Complementation of an Escherichia coli adhE mutant by the Entamoeba histolytica EhADH2 gene provides a method for the identification of new antiamebic drugs (Q37524185) (← links)
• Parasitic diseases in travelers: a focus on therapy (Q38192001) (← links)
• Management of chronic Giardia infection (Q38233620) (← links)
• Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase (Q39580129) (← links)
• Inhibition of pyruvate-ferredoxin oxidoreductase gene expression in Giardia lamblia by a virus-mediated hammerhead ribozyme (Q40882604) (← links)
• The mechanisms of action of antiprotozoal and anthelmintic drugs in man. (Q41333897) (← links)
• Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation (Q41352700) (← links)
• Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia (Q42116901) (← links)
• Synthesis and in vitro antiprotozoal activity of 5-nitrothiophene-2-carboxaldehyde thiosemicarbazone derivatives. (Q44207196) (← links)
• Efficacy of Drontal Flavour Plus (50 mg praziquantel, 144 mg pyrantel embonate, 150 mg febantel per tablet) against Giardia sp in naturally infected dogs (Q46459928) (← links)
• The effects of saturated fatty acids on Giardia duodenalis trophozoites in vitro (Q46577880) (← links)
• My favorite cell: Giardia (Q47758372) (← links)
• Management of giardiasis by a herbal drug 'Pippali Rasayana': a clinical study (Q47792293) (← links)
• Analysis of nucleotide variation within the triose-phosphate isomerase gene of Giardia duodenalis from sheep and its zoonotic implications (Q48066310) (← links)
• A simple colourimetric method to determine anti-giardial activity of drugs (Q50470500) (← links)
• Physiological aspects of nitro drug resistance in Giardia lamblia. (Q53685914) (← links)
• [Trichomonas vaginalis: treatment and resistance to nitroimidazoles]. (Q54011056) (← links)
• Treatment of giardiasis. (Q55034504) (← links)
• Resistance formation to nitro drugs in Giardia lamblia: No common markers identified by comparative proteomics (Q64087646) (← links)
• On the molecular and cellular effects of omeprazole to further support its effectiveness as an antigiardial drug. (Q64880222) (← links)
• In vitro drug susceptibility of 29 isolates of Giardia duodenalis from humans as assessed by an adhesion assay (Q71959500) (← links)
• Drug resistance in Giardia: clinical versus laboratory isolates (Q79340355) (← links)
• Effect of metronidazole analogues on Giardia lamblia cultures (Q81376730) (← links)
• In vitro antiamoebic activity evaluation and docking studies of metronidazole-triazole hybrids (Q87637133) (← links)